Last updated: 2026-09-21 05:01:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Whitehawk Therapeutics, Inc. (WHWK) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $4,18, with a market capitalization of $239,44M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1,82 to $5,50. This page covers its latest market performance, valuation, price trends and company information.
$239,44M | |
$4,09 | |
$5,50 | |
$1,39 | |
$4,08 | |
222,47K | |
482,91K | |
-- | |
$5,50 | |
$1,82 | |
-- | |
-- |
Whitehawk Therapeutics, Inc. (WHWK) last closed at $4,08 as of 2026-09-18 23:31:00, unchanged from the previous close of $4,08.
During the latest regular trading session, WHWK traded between $1,39 and $5,50, with a volume of 222,47K shares. The closing price was near the middle and near the middle of its 52-week range.
Over the past seven days, Whitehawk Therapeutics, Inc. (WHWK) moved from $4,07 to $4,18, representing a gain of 2,58% ($0,10).
The stock traded between $3,96 and $4,30 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 593,75 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 64,1%
WHWK is currently trading at $4,18, placing it 64,1% of the way from its 52-week low of $1,82 to its 52-week high of $5,50. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 23 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Whitehawk Therapeutics, Inc. (WHWK) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.